InvestorsHub Logo
Followers 152
Posts 2303
Boards Moderated 0
Alias Born 01/24/2012

Re: None

Saturday, 10/20/2018 4:38:42 PM

Saturday, October 20, 2018 4:38:42 PM

Post# of 638
EyePoint Pharma shares jump on FDA approval of Yutiq implant

EyePoint Pharmaceuticals Inc. shares EYPT, -10.17%soared 8% in premarket trade Monday, after the company said the U.S. Food and Drug Administration has approved its Yutiq implant for the treatment of uveitis, a leading cause of blindness. Yutiq is a micro-insert that is designed to release fluocinolone acetonide over a three-year period and that can be administered in a doctor's office. :Chronic non-infectious uveitis affecting the posterior segment of the eye is the third leading cause of blindness in the U.S.," Chief Executive Nancy Lurker said in a statement. The company is expecting to launch the product in the first quarter of 2019. EyePoint shares have gained 199% in 2018, while the S&P 500 SPX, -0.04%has gained 3.5%.

Was not sure if this news has been shared, but I hope it Helps.

GLTA.
Cheers!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EYPT News